The chief executive of the American pharmaceutical industry company Pfizer Inc. has warned poor countries to “place orders” soon.
Albert Bourla made the comments amid projections that the company’s total sales were about to reach at least $65 billion from sales of its coronavirus vaccines.
"The high-income countries, they have the tendency to be way more proactive, and they are placing their orders," Bourla said in an interview. "I want to make sure that I go on record publicly... they need to place orders, period."
The Covid-19 vaccine that the New York-based multinational pharmaceutical and biotechnology corporation has developed with German partner BioNTech SE is reportedly selling for $36 billion is 2021 and another $29 billion in 2022.
The chief executive vowed to continue supporting the US government in its vaccination effort, which is supposed to reduce the number of hospitalizations and deaths in the United States.
In the state of Colorado for example, surging infections are reportedly leading to rationing hospital care, although some 80 percent of the population have received at least one dose of the shot.
"As long as the government thinks they should be going with mass vaccinations that they buy and distribute, we will support them," Bourla said.
So far, over 747 thousand people have died in the United States out of over the 46 million cases reported.
The US mandate for vaccines means American vaccine makers such as Pfizer and Johnson & Johnson are going to reap billions of dollars from annual vaccine boosters over the next few years.